Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Journal of Surgery and Research|October 13, 2023
Simultaneous Bladder Drainage via Suprapubic and Urethral Catheters: Which Drains More Completely and Why?Aurash Naser-Tavakolian, John M Masterson, Jeremiah Dallmer, et al.Journal of the Air & Waste Management Association (1995)|April 10, 2018
Open-path, closed-path, and reconstructed aerosol extinction at a rural siteTimothy D Gordon, Anthony J Prenni, James R Renfro, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2012
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studiesPatricia A Deverka, Sheri D Schully, Naoko Ishibe, et al.Journal of Pediatric Urology|June 11, 2024
Application of intraoperative structured light scanning to enable post-operative evaluation of digital and 3D-printed penile modelsAlen Huang, Victoria Lee, Akash E Chauhan, et al.Urology|December 8, 2022
Management and Outcomes of Ileal Pouch-Urethral FistulasJoão Pedro Emrich Accioly, Mariana Maspero, Hanson Zhao, et al.Ecancermedicalscience|November 12, 2015
Aspirin in the 21st century-common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UKTom Smith, Pippa Hutchison, Karsten Schrör, et al.Urology|July 20, 2020
Outcomes of Prophylactic Mid-Urethral Sling at the Time of Robotic SacrocolpopexyCarrie A Stewart, Shreeya Popat, Hanson Zhao, et al.European Journal of Immunology|June 2, 2012
Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunityTom Pembroke, Ian Rees, Kathleen Gallagher, et al.Plos One|April 13, 2011
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCristina Cellerai, Alexandre Harari, Hans Stauss, et al.Le Infezioni in Medicina|December 18, 2019
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort studyGianmaria Baldin, Arturo Ciccullo, Stefano Rusconi, et al.Pageof 7